JPWO2022253341A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022253341A5 JPWO2022253341A5 JP2023574635A JP2023574635A JPWO2022253341A5 JP WO2022253341 A5 JPWO2022253341 A5 JP WO2022253341A5 JP 2023574635 A JP2023574635 A JP 2023574635A JP 2023574635 A JP2023574635 A JP 2023574635A JP WO2022253341 A5 JPWO2022253341 A5 JP WO2022253341A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- optionally substituted
- independently selected
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021098358 | 2021-06-04 | ||
| CNPCT/CN2021/098358 | 2021-06-04 | ||
| PCT/CN2022/097025 WO2022253341A1 (en) | 2021-06-04 | 2022-06-03 | 2, 8-diazaspiro [4.5] decane compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024521929A JP2024521929A (ja) | 2024-06-04 |
| JP2024521929A5 JP2024521929A5 (https=) | 2025-06-12 |
| JPWO2022253341A5 true JPWO2022253341A5 (https=) | 2025-06-12 |
Family
ID=84322789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023574635A Pending JP2024521929A (ja) | 2021-06-04 | 2022-06-03 | ２，８－ジアザスピロ［４．５］デカン化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240174696A1 (https=) |
| EP (1) | EP4347594A4 (https=) |
| JP (1) | JP2024521929A (https=) |
| KR (1) | KR20240016977A (https=) |
| CN (1) | CN117425654A (https=) |
| AR (1) | AR126078A1 (https=) |
| AU (1) | AU2022284188A1 (https=) |
| BR (1) | BR112023025393A2 (https=) |
| CA (1) | CA3222054A1 (https=) |
| TW (1) | TW202313608A (https=) |
| WO (1) | WO2022253341A1 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101679418A (zh) * | 2007-04-06 | 2010-03-24 | 诺瓦提斯公司 | 用作蛋白质激酶抑制剂的[2,6]萘啶类化合物 |
| JP2011529932A (ja) * | 2008-08-05 | 2011-12-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 置換ナフチリジン及び医薬としてのその使用 |
| WO2012167423A1 (en) * | 2011-06-08 | 2012-12-13 | Hutchison Medipharma Limited | Substituted pyridopyrazines as novel syk inhibitors |
| KR20140048216A (ko) * | 2011-06-29 | 2014-04-23 | 오츠카 세이야쿠 가부시키가이샤 | 치료 화합물로서의 퀴나졸린 및 관련된 사용 방법 |
| TWI675836B (zh) * | 2014-03-25 | 2019-11-01 | 美商伊格尼塔公司 | 非典型蛋白質激酶ｃ之氮雜喹唑啉抑制劑 |
| JOP20190257A1 (ar) * | 2017-04-28 | 2019-10-28 | Novartis Ag | مركبات أريل غير متجانسة ثنائية الحلقة مندمجة 6-6 واستخدامها كمثبطات lats |
| KR102328435B1 (ko) * | 2018-09-11 | 2021-11-18 | 재단법인 대구경북첨단의료산업진흥재단 | 신규 피리도-피리미딘 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 단백질 키나아제 관련 질환의 예방 또는 치료용 약학적 조성물 |
| WO2021050059A1 (en) * | 2019-09-11 | 2021-03-18 | Provincial Health Services Authority | Dna-pk inhibiting compounds |
-
2022
- 2022-06-03 JP JP2023574635A patent/JP2024521929A/ja active Pending
- 2022-06-03 AU AU2022284188A patent/AU2022284188A1/en active Pending
- 2022-06-03 CA CA3222054A patent/CA3222054A1/en active Pending
- 2022-06-03 BR BR112023025393A patent/BR112023025393A2/pt unknown
- 2022-06-03 AR ARP220101483A patent/AR126078A1/es not_active Application Discontinuation
- 2022-06-03 TW TW111120777A patent/TW202313608A/zh unknown
- 2022-06-03 WO PCT/CN2022/097025 patent/WO2022253341A1/en not_active Ceased
- 2022-06-03 EP EP22815380.5A patent/EP4347594A4/en active Pending
- 2022-06-03 KR KR1020237042291A patent/KR20240016977A/ko active Pending
- 2022-06-03 CN CN202280039813.4A patent/CN117425654A/zh active Pending
-
2023
- 2023-12-01 US US18/526,572 patent/US20240174696A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7579805B2 (ja) | アミノ酸化合物の剤形およびレジメン | |
| AU766081B2 (en) | Phthalazine derivatives for treating inflammatory diseases | |
| JP4724665B2 (ja) | キノリノン化合物を合成する方法 | |
| JP3397320B2 (ja) | 縮合イミダゾリウム誘導体 | |
| JP3223169B2 (ja) | コルチコトロピン放出因子アンタゴニスト製造用中間体 | |
| JP2021534124A5 (https=) | ||
| JP2019527731A (ja) | Ｈｂｖ感染の治療のための新規治療薬 | |
| KR20150114480A (ko) | Hbv 감염에 대한 항바이러스 물질 | |
| JP2005514398A5 (https=) | ||
| JP2021523225A5 (https=) | ||
| JP2005508960A5 (https=) | ||
| MXPA03011629A (es) | Derivado de fenilpiridincarbonilpiperazina. | |
| JP7762306B2 (ja) | 選択的ｐａｒｐ１阻害剤およびその用途 | |
| JP2010502706A5 (https=) | ||
| IL127036A (en) | History of Inverted Indazol and Phdephodesterase (PDE) IV and TNF-Containing Pharmaceuticals Containing Them | |
| CN114008028A (zh) | 抑制癌细胞生长的嘧啶衍生物及其医药用途 | |
| WO2020150210A1 (en) | Tetrazolone substituted steroids and use thereof | |
| JP2024003167A5 (https=) | ||
| JPWO2021222404A5 (https=) | ||
| AU2021328979B2 (en) | Pyrazole boronic acid compound, pharmaceutical composition containing same, and uses thereof | |
| EP4622713A1 (en) | Compounds and compositions for treating conditions associated with lpa receptor activity | |
| JPWO2022253341A5 (https=) | ||
| JP7168245B2 (ja) | 三環式化合物 | |
| JPWO2020132504A5 (https=) | ||
| JPWO2021076691A5 (https=) |